B
Quest Diagnostics Incorporated
DGX
$175.56
$3.892.27%
B
Buy
2/24/2025Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to B- from C+ on 2/24/2025 due to an increase in the growth index, volatility index and total return index. Operating cash flow increased 30.34% from $356M to $464M, total revenue increased 5.35% from $2.49B to $2.62B, and EBIT increased 4.25% from $353M to $368M.
Quest Diagnostics Incorporated (DGX) was upgraded to B- from C+ on 2/24/2025 due to an increase in the growth index, volatility index and total return index. Operating cash flow increased 30.34% from $356M to $464M, total revenue increased 5.35% from $2.49B to $2.62B, and EBIT increased 4.25% from $353M to $368M.
C
Hold
1/14/2025Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to C+ from C on 1/14/2025 due to an increase in the volatility index.
Quest Diagnostics Incorporated (DGX) was upgraded to C+ from C on 1/14/2025 due to an increase in the volatility index.
C
Hold
12/30/2024Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to C from C+ on 12/30/2024 due to a decline in the total return index.
Quest Diagnostics Incorporated (DGX) was downgraded to C from C+ on 12/30/2024 due to a decline in the total return index.
C
Hold
11/11/2024Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to C+ from C on 11/11/2024 due to an increase in the volatility index.
Quest Diagnostics Incorporated (DGX) was upgraded to C+ from C on 11/11/2024 due to an increase in the volatility index.
C
Hold
10/7/2024Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to C from C+ on 10/7/2024 due to a decline in the volatility index.
Quest Diagnostics Incorporated (DGX) was downgraded to C from C+ on 10/7/2024 due to a decline in the volatility index.
C
Hold
9/20/2024Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to C+ from C on 9/20/2024 due to an increase in the total return index and valuation index.
Quest Diagnostics Incorporated (DGX) was upgraded to C+ from C on 9/20/2024 due to an increase in the total return index and valuation index.
C
Hold
9/5/2024Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to C from C+ on 9/5/2024 due to a decline in the valuation index, volatility index and dividend index.
Quest Diagnostics Incorporated (DGX) was downgraded to C from C+ on 9/5/2024 due to a decline in the valuation index, volatility index and dividend index.
C
Hold
8/8/2024Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to C+ from C on 8/8/2024 due to a large increase in the total return index, volatility index and growth index. Operating cash flow increased 133.77% from $154M to $360M, earnings per share increased from $1.72 to $2.03, and EBIT increased 17.35% from $317M to $372M.
Quest Diagnostics Incorporated (DGX) was upgraded to C+ from C on 8/8/2024 due to a large increase in the total return index, volatility index and growth index. Operating cash flow increased 133.77% from $154M to $360M, earnings per share increased from $1.72 to $2.03, and EBIT increased 17.35% from $317M to $372M.
C
Hold
11/30/2023Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to C from C- on 11/30/2023 due to an increase in the volatility index.
Quest Diagnostics Incorporated (DGX) was upgraded to C from C- on 11/30/2023 due to an increase in the volatility index.
C
Hold
10/27/2023Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to C- from C on 10/27/2023 due to a significant decline in the growth index, total return index and volatility index. Operating cash flow declined 53.38% from $444M to $207M, earnings per share declined from $2.05 to $1.96, and EBIT declined 2.22% from $361M to $353M.
Quest Diagnostics Incorporated (DGX) was downgraded to C- from C on 10/27/2023 due to a significant decline in the growth index, total return index and volatility index. Operating cash flow declined 53.38% from $444M to $207M, earnings per share declined from $2.05 to $1.96, and EBIT declined 2.22% from $361M to $353M.
C
Hold
9/29/2023Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to C from C+ on 9/29/2023 due to a decline in the volatility index and total return index.
Quest Diagnostics Incorporated (DGX) was downgraded to C from C+ on 9/29/2023 due to a decline in the volatility index and total return index.
C
Hold
8/22/2023Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to C+ from B- on 8/22/2023 due to a decline in the efficiency index, growth index and volatility index.
Quest Diagnostics Incorporated (DGX) was downgraded to C+ from B- on 8/22/2023 due to a decline in the efficiency index, growth index and volatility index.
B
Buy
7/31/2023Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to B- from C+ on 7/31/2023 due to a noticeable increase in the growth index and valuation index. Operating cash flow increased 372.34% from $94M to $444M, earnings per share increased from $1.78 to $2.05, and EBIT increased 11.42% from $324M to $361M.
Quest Diagnostics Incorporated (DGX) was upgraded to B- from C+ on 7/31/2023 due to a noticeable increase in the growth index and valuation index. Operating cash flow increased 372.34% from $94M to $444M, earnings per share increased from $1.78 to $2.05, and EBIT increased 11.42% from $324M to $361M.
C
Hold
7/12/2023Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to C+ from B- on 7/12/2023 due to a decline in the volatility index, valuation index and total return index.
Quest Diagnostics Incorporated (DGX) was downgraded to C+ from B- on 7/12/2023 due to a decline in the volatility index, valuation index and total return index.
B
Buy
6/27/2023Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to B- from C+ on 6/27/2023 due to an increase in the volatility index and total return index.
Quest Diagnostics Incorporated (DGX) was upgraded to B- from C+ on 6/27/2023 due to an increase in the volatility index and total return index.
C
Hold
6/12/2023Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to C+ from B- on 6/12/2023 due to a decline in the volatility index, total return index and valuation index.
Quest Diagnostics Incorporated (DGX) was downgraded to C+ from B- on 6/12/2023 due to a decline in the volatility index, total return index and valuation index.
B
Buy
5/26/2023Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to B- from C+ on 5/26/2023 due to an increase in the valuation index, volatility index and dividend index.
Quest Diagnostics Incorporated (DGX) was upgraded to B- from C+ on 5/26/2023 due to an increase in the valuation index, volatility index and dividend index.
C
Hold
5/11/2023Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to C+ from B- on 5/11/2023 due to a decline in the total return index, volatility index and valuation index.
Quest Diagnostics Incorporated (DGX) was downgraded to C+ from B- on 5/11/2023 due to a decline in the total return index, volatility index and valuation index.
B
Buy
2/23/2023Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to B- from B on 2/23/2023 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from $2.17 to $0.8827, EBIT declined 42.75% from $386M to $221M, and operating cash flow declined 33.47% from $502M to $334M.
Quest Diagnostics Incorporated (DGX) was downgraded to B- from B on 2/23/2023 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from $2.17 to $0.8827, EBIT declined 42.75% from $386M to $221M, and operating cash flow declined 33.47% from $502M to $334M.
B
Buy
2/10/2023Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to B from B- on 2/10/2023 due to an increase in the total return index and volatility index.
Quest Diagnostics Incorporated (DGX) was upgraded to B from B- on 2/10/2023 due to an increase in the total return index and volatility index.
B
Buy
1/26/2023Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to B- from B on 1/26/2023 due to a decline in the volatility index.
Quest Diagnostics Incorporated (DGX) was downgraded to B- from B on 1/26/2023 due to a decline in the volatility index.
B
Buy
1/11/2023Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to B from B- on 1/11/2023 due to an increase in the volatility index and total return index.
Quest Diagnostics Incorporated (DGX) was upgraded to B from B- on 1/11/2023 due to an increase in the volatility index and total return index.
B
Buy
12/2/2022Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to B- from C+ on 12/2/2022 due to an increase in the growth index, volatility index and total return index. Operating cash flow increased 24.88% from $402M to $502M, earnings per share increased from $1.96 to $2.17, and total revenue increased 1.35% from $2.45B to $2.49B.
Quest Diagnostics Incorporated (DGX) was upgraded to B- from C+ on 12/2/2022 due to an increase in the growth index, volatility index and total return index. Operating cash flow increased 24.88% from $402M to $502M, earnings per share increased from $1.96 to $2.17, and total revenue increased 1.35% from $2.45B to $2.49B.
C
Hold
9/30/2022Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to C+ from B- on 9/30/2022 due to a decline in the volatility index and total return index.
Quest Diagnostics Incorporated (DGX) was downgraded to C+ from B- on 9/30/2022 due to a decline in the volatility index and total return index.
B
Buy
8/29/2022Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to B- from B on 8/29/2022 due to a substantial decline in the growth index, valuation index and volatility index. Earnings per share declined from $2.92 to $1.96, EBIT declined 23.43% from $525M to $402M, and operating cash flow declined 16.25% from $480M to $402M.
Quest Diagnostics Incorporated (DGX) was downgraded to B- from B on 8/29/2022 due to a substantial decline in the growth index, valuation index and volatility index. Earnings per share declined from $2.92 to $1.96, EBIT declined 23.43% from $525M to $402M, and operating cash flow declined 16.25% from $480M to $402M.
B
Buy
1/21/2022Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to B from B+ on 1/21/2022 due to a major decline in the total return index and volatility index.
Quest Diagnostics Incorporated (DGX) was downgraded to B from B+ on 1/21/2022 due to a major decline in the total return index and volatility index.
B
Buy
1/7/2022Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to B+ from A- on 1/7/2022 due to a large decline in the total return index.
Quest Diagnostics Incorporated (DGX) was downgraded to B+ from A- on 1/7/2022 due to a large decline in the total return index.
A
Buy
12/20/2021Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to A- from B+ on 12/20/2021 due to a noticeable increase in the total return index and volatility index.
Quest Diagnostics Incorporated (DGX) was upgraded to A- from B+ on 12/20/2021 due to a noticeable increase in the total return index and volatility index.
B
Buy
11/29/2021Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to B+ from B on 11/29/2021 due to a major increase in the total return index, volatility index and growth index. Operating cash flow increased 21.96% from $460M to $561M, EBIT increased 20.04% from $554M to $665M, and total revenue increased 8.78% from $2.55B to $2.77B.
Quest Diagnostics Incorporated (DGX) was upgraded to B+ from B on 11/29/2021 due to a major increase in the total return index, volatility index and growth index. Operating cash flow increased 21.96% from $460M to $561M, EBIT increased 20.04% from $554M to $665M, and total revenue increased 8.78% from $2.55B to $2.77B.
B
Buy
4/26/2021Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to B from B- on 4/26/2021 due to an increase in the valuation index, volatility index and efficiency index.
Quest Diagnostics Incorporated (DGX) was upgraded to B from B- on 4/26/2021 due to an increase in the valuation index, volatility index and efficiency index.
B
Buy
3/26/2021Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to B- from B on 3/26/2021 due to a decline in the volatility index, valuation index and dividend index.
Quest Diagnostics Incorporated (DGX) was downgraded to B- from B on 3/26/2021 due to a decline in the volatility index, valuation index and dividend index.
B
Buy
3/11/2021Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to B from B- on 3/11/2021 due to an increase in the volatility index, valuation index and dividend index.
Quest Diagnostics Incorporated (DGX) was upgraded to B from B- on 3/11/2021 due to an increase in the volatility index, valuation index and dividend index.
B
Buy
2/24/2021Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to B- from B on 2/24/2021 due to a decline in the growth index and total return index. Operating cash flow declined 37.24% from $862M to $541M.
Quest Diagnostics Incorporated (DGX) was downgraded to B- from B on 2/24/2021 due to a decline in the growth index and total return index. Operating cash flow declined 37.24% from $862M to $541M.
B
Buy
10/26/2020Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to B from B- on 10/26/2020 due to a substantial increase in the growth index, valuation index and efficiency index. Net income increased 207.03% from $185M to $568M, earnings per share increased from $1.36 to $4.14, and EBIT increased 193.43% from $274M to $804M.
Quest Diagnostics Incorporated (DGX) was upgraded to B from B- on 10/26/2020 due to a substantial increase in the growth index, valuation index and efficiency index. Net income increased 207.03% from $185M to $568M, earnings per share increased from $1.36 to $4.14, and EBIT increased 193.43% from $274M to $804M.
B
Buy
10/19/2020Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to B- from C+ on 10/19/2020 due to a large increase in the growth index, volatility index and total return index. Earnings per share increased from $0.73 to $1.36, operating cash flow increased 43.72% from $247M to $355M, and EBIT increased 37.69% from $199M to $274M.
Quest Diagnostics Incorporated (DGX) was upgraded to B- from C+ on 10/19/2020 due to a large increase in the growth index, volatility index and total return index. Earnings per share increased from $0.73 to $1.36, operating cash flow increased 43.72% from $247M to $355M, and EBIT increased 37.69% from $199M to $274M.
C
Hold
7/9/2020Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to C+ from C on 7/9/2020 due to a noticeable increase in the total return index and volatility index.
Quest Diagnostics Incorporated (DGX) was upgraded to C+ from C on 7/9/2020 due to a noticeable increase in the total return index and volatility index.
C
Hold
6/24/2020Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to C from C+ on 6/24/2020 due to a decline in the solvency index, volatility index and total return index.
Quest Diagnostics Incorporated (DGX) was downgraded to C from C+ on 6/24/2020 due to a decline in the solvency index, volatility index and total return index.
C
Hold
6/9/2020Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to C+ from C on 6/9/2020 due to an increase in the volatility index and solvency index.
Quest Diagnostics Incorporated (DGX) was upgraded to C+ from C on 6/9/2020 due to an increase in the volatility index and solvency index.
C
Hold
5/6/2020Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to C from C+ on 5/6/2020 due to a noticeable decline in the growth index, valuation index and volatility index. Earnings per share declined from $1.86 to $0.73, EBIT declined 34.54% from $304M to $199M, and operating cash flow declined 29.02% from $348M to $247M.
Quest Diagnostics Incorporated (DGX) was downgraded to C from C+ on 5/6/2020 due to a noticeable decline in the growth index, valuation index and volatility index. Earnings per share declined from $1.86 to $0.73, EBIT declined 34.54% from $304M to $199M, and operating cash flow declined 29.02% from $348M to $247M.
C
Hold
4/27/2020Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to C+ from C on 4/27/2020 due to an increase in the volatility index, solvency index and valuation index.
Quest Diagnostics Incorporated (DGX) was upgraded to C+ from C on 4/27/2020 due to an increase in the volatility index, solvency index and valuation index.
C
Hold
3/18/2020Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to C from C+ on 3/18/2020 due to a noticeable decline in the volatility index and total return index.
Quest Diagnostics Incorporated (DGX) was downgraded to C from C+ on 3/18/2020 due to a noticeable decline in the volatility index and total return index.
C
Hold
3/9/2020Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to C+ from B- on 3/9/2020 due to a decline in the volatility index.
Quest Diagnostics Incorporated (DGX) was downgraded to C+ from B- on 3/9/2020 due to a decline in the volatility index.
B
Buy
2/21/2020Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to B- from C+ on 2/21/2020 due to a noticeable increase in the growth index, valuation index and solvency index. The quick ratio increased from 0.77 to 1.13, earnings per share increased from $1.56 to $1.86, and operating cash flow increased 16.39% from $299M to $348M.
Quest Diagnostics Incorporated (DGX) was upgraded to B- from C+ on 2/21/2020 due to a noticeable increase in the growth index, valuation index and solvency index. The quick ratio increased from 0.77 to 1.13, earnings per share increased from $1.56 to $1.86, and operating cash flow increased 16.39% from $299M to $348M.
C
Hold
12/24/2019Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to C+ from B- on 12/24/2019 due to a decline in the volatility index, valuation index and dividend index.
Quest Diagnostics Incorporated (DGX) was downgraded to C+ from B- on 12/24/2019 due to a decline in the volatility index, valuation index and dividend index.
B
Buy
11/13/2019Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to B- from C+ on 11/13/2019 due to an increase in the volatility index, total return index and solvency index.
Quest Diagnostics Incorporated (DGX) was upgraded to B- from C+ on 11/13/2019 due to an increase in the volatility index, total return index and solvency index.
C
Hold
10/29/2019Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to C+ from B- on 10/29/2019 due to a major decline in the growth index, solvency index and efficiency index. Operating cash flow declined 6.85% from $321M to $299M, earnings per share declined from $1.6571 to $1.56, and net income declined 4.87% from $226M to $215M.
Quest Diagnostics Incorporated (DGX) was downgraded to C+ from B- on 10/29/2019 due to a major decline in the growth index, solvency index and efficiency index. Operating cash flow declined 6.85% from $321M to $299M, earnings per share declined from $1.6571 to $1.56, and net income declined 4.87% from $226M to $215M.
B
Buy
10/14/2019Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to B- from C+ on 10/14/2019 due to a noticeable increase in the growth index, volatility index and total return index. Earnings per share increased from $1.2 to $1.6571, EBIT increased 25.77% from $260M to $327M, and operating cash flow increased 16.73% from $275M to $321M.
Quest Diagnostics Incorporated (DGX) was upgraded to B- from C+ on 10/14/2019 due to a noticeable increase in the growth index, volatility index and total return index. Earnings per share increased from $1.2 to $1.6571, EBIT increased 25.77% from $260M to $327M, and operating cash flow increased 16.73% from $275M to $321M.
C
Hold
5/21/2019Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to C+ from C on 5/21/2019 due to an increase in the volatility index.
Quest Diagnostics Incorporated (DGX) was upgraded to C+ from C on 5/21/2019 due to an increase in the volatility index.
C
Hold
1/3/2019Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to C from C+ on 1/3/2019 due to a decline in the volatility index and total return index.
Quest Diagnostics Incorporated (DGX) was downgraded to C from C+ on 1/3/2019 due to a decline in the volatility index and total return index.
C
Hold
12/18/2018Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to C+ from B- on 12/18/2018 due to a noticeable decline in the volatility index and total return index.
Quest Diagnostics Incorporated (DGX) was downgraded to C+ from B- on 12/18/2018 due to a noticeable decline in the volatility index and total return index.
B
Buy
11/29/2018Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to B- from B on 11/29/2018 due to a noticeable decline in the volatility index, growth index and total return index. EBIT declined 5.76% from $330M to $311M, earnings per share declined from $1.57 to $1.53, and total revenue declined 1.56% from $1.92B to $1.89B.
Quest Diagnostics Incorporated (DGX) was downgraded to B- from B on 11/29/2018 due to a noticeable decline in the volatility index, growth index and total return index. EBIT declined 5.76% from $330M to $311M, earnings per share declined from $1.57 to $1.53, and total revenue declined 1.56% from $1.92B to $1.89B.
B
Buy
10/11/2018Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to B from B+ on 10/11/2018 due to a decline in the total return index and volatility index.
Quest Diagnostics Incorporated (DGX) was downgraded to B from B+ on 10/11/2018 due to a decline in the total return index and volatility index.
B
Buy
9/24/2018Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to B+ from B on 9/24/2018 due to a major increase in the growth index, volatility index and valuation index. Operating cash flow increased 79.44% from $180M to $323M, earnings per share increased from $1.27 to $1.57, and EBIT increased 8.55% from $304M to $330M.
Quest Diagnostics Incorporated (DGX) was upgraded to B+ from B on 9/24/2018 due to a major increase in the growth index, volatility index and valuation index. Operating cash flow increased 79.44% from $180M to $323M, earnings per share increased from $1.27 to $1.57, and EBIT increased 8.55% from $304M to $330M.
B
Buy
1/10/2018Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to B from B- on 1/10/2018 due to an increase in the volatility index and total return index.
Quest Diagnostics Incorporated (DGX) was upgraded to B from B- on 1/10/2018 due to an increase in the volatility index and total return index.
B
Buy
12/26/2017Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to B- from B on 12/26/2017 due to a large decline in the volatility index, growth index and total return index. Earnings per share declined from $1.37 to $1.1429, EBIT declined 11.14% from $341M to $303M, and total revenue declined 0.62% from $1.94B to $1.93B.
Quest Diagnostics Incorporated (DGX) was downgraded to B- from B on 12/26/2017 due to a large decline in the volatility index, growth index and total return index. Earnings per share declined from $1.37 to $1.1429, EBIT declined 11.14% from $341M to $303M, and total revenue declined 0.62% from $1.94B to $1.93B.
B
Buy
9/25/2017Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to B from B+ on 9/25/2017 due to a large decline in the total return index and volatility index.
Quest Diagnostics Incorporated (DGX) was downgraded to B from B+ on 9/25/2017 due to a large decline in the total return index and volatility index.
B
Buy
8/28/2017Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to B+ from A- on 8/28/2017 due to a large decline in the total return index.
Quest Diagnostics Incorporated (DGX) was downgraded to B+ from A- on 8/28/2017 due to a large decline in the total return index.
A
Buy
8/17/2017Downgrade
Quest Diagnostics Incorporated (DGX) was downgraded to A- from A on 8/17/2017 due to a noticeable decline in the total return index.
Quest Diagnostics Incorporated (DGX) was downgraded to A- from A on 8/17/2017 due to a noticeable decline in the total return index.
A
Buy
7/5/2017Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to A from A- on 7/5/2017 due to an increase in the volatility index and total return index.
Quest Diagnostics Incorporated (DGX) was upgraded to A from A- on 7/5/2017 due to an increase in the volatility index and total return index.
A
Buy
5/10/2017Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to A- from B+ on 5/10/2017 due to an increase in the volatility index and total return index.
Quest Diagnostics Incorporated (DGX) was upgraded to A- from B+ on 5/10/2017 due to an increase in the volatility index and total return index.
B
Buy
5/3/2017Upgraded
Quest Diagnostics Incorporated (DGX) was upgraded to B+ from B on 5/3/2017 due to a noticeable increase in the growth index, total return index and volatility index. EBIT increased 12.08% from $265M to $297M, earnings per share increased from $1.0735 to $1.16, and total revenue increased 2.04% from $1.86B to $1.9B.
Quest Diagnostics Incorporated (DGX) was upgraded to B+ from B on 5/3/2017 due to a noticeable increase in the growth index, total return index and volatility index. EBIT increased 12.08% from $265M to $297M, earnings per share increased from $1.0735 to $1.16, and total revenue increased 2.04% from $1.86B to $1.9B.
B
Buy
10/26/2016Downgrade
Quest Diagnostics Inc. (DGX) was downgraded to B from B+ on 10/26/2016 due to a significant decline in the growth index, valuation index and efficiency index. Operating cash flow declined 6.23% from $321M to $301M, earnings per share declined from $1.37 to $1.34, and net income declined 1.54% from $195M to $192M.
Quest Diagnostics Inc. (DGX) was downgraded to B from B+ on 10/26/2016 due to a significant decline in the growth index, valuation index and efficiency index. Operating cash flow declined 6.23% from $321M to $301M, earnings per share declined from $1.37 to $1.34, and net income declined 1.54% from $195M to $192M.
B
Buy
8/29/2016Upgraded
Quest Diagnostics Inc. (DGX) was upgraded to B+ from B on 8/29/2016 due to a significant increase in the total return index, growth index and volatility index. Operating cash flow increased 124.48% from $143M to $321M, earnings per share increased from $0.7 to $1.37, and EBIT increased 15.66% from $281M to $325M.
Quest Diagnostics Inc. (DGX) was upgraded to B+ from B on 8/29/2016 due to a significant increase in the total return index, growth index and volatility index. Operating cash flow increased 124.48% from $143M to $321M, earnings per share increased from $0.7 to $1.37, and EBIT increased 15.66% from $281M to $325M.
B
Buy
5/3/2016Upgraded
Quest Diagnostics Inc. (DGX) was upgraded to B from B- on 5/3/2016 due to an increase in the volatility index and valuation index.
Quest Diagnostics Inc. (DGX) was upgraded to B from B- on 5/3/2016 due to an increase in the volatility index and valuation index.
B
Buy
3/28/2016Downgrade
Quest Diagnostics Inc. (DGX) was downgraded to B- from B on 3/28/2016 due to a decline in the total return index, valuation index and volatility index.
Quest Diagnostics Inc. (DGX) was downgraded to B- from B on 3/28/2016 due to a decline in the total return index, valuation index and volatility index.
B
Buy
1/21/2016Upgraded
Quest Diagnostics Inc. (DGX) was upgraded to B from B- on 1/21/2016 due to an increase in the valuation index, dividend index and total return index.
Quest Diagnostics Inc. (DGX) was upgraded to B from B- on 1/21/2016 due to an increase in the valuation index, dividend index and total return index.
B
Buy
1/6/2016Downgrade
Quest Diagnostics Inc. (DGX) was downgraded to B- from B on 1/6/2016 due to a decline in the valuation index, volatility index and total return index.
Quest Diagnostics Inc. (DGX) was downgraded to B- from B on 1/6/2016 due to a decline in the valuation index, volatility index and total return index.
B
Buy
10/30/2015Upgraded
Quest Diagnostics Inc. (DGX) was upgraded to B from B- on 10/30/2015 due to a large increase in the valuation index, efficiency index and solvency index. Net income increased 189.83% from $118M to $342M, the quick ratio increased from 0.88 to 0.94, and debt to equity declined from 0.86 to 0.81.
Quest Diagnostics Inc. (DGX) was upgraded to B from B- on 10/30/2015 due to a large increase in the valuation index, efficiency index and solvency index. Net income increased 189.83% from $118M to $342M, the quick ratio increased from 0.88 to 0.94, and debt to equity declined from 0.86 to 0.81.
B
Buy
9/28/2015Downgrade
Quest Diagnostics Inc. (DGX) was downgraded to B- from B on 9/28/2015 due to a noticeable decline in the volatility index, valuation index and efficiency index. Total capital declined 10.16% from $9.01B to $8.09B.
Quest Diagnostics Inc. (DGX) was downgraded to B- from B on 9/28/2015 due to a noticeable decline in the volatility index, valuation index and efficiency index. Total capital declined 10.16% from $9.01B to $8.09B.
B
Buy
10/31/2014Downgrade
Quest Diagnostics Inc. (DGX) was downgraded to B from B+ on 10/31/2014 due to a substantial decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.92 to $0.88, operating cash flow declined 3.21% from $280M to $271M, and net income declined 3.01% from $133M to $129M.
Quest Diagnostics Inc. (DGX) was downgraded to B from B+ on 10/31/2014 due to a substantial decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.92 to $0.88, operating cash flow declined 3.21% from $280M to $271M, and net income declined 3.01% from $133M to $129M.
B
Buy
10/28/2014Upgraded
Quest Diagnostics Inc. (DGX) was upgraded to B+ from B on 10/28/2014 due to an increase in the volatility index and total return index.
Quest Diagnostics Inc. (DGX) was upgraded to B+ from B on 10/28/2014 due to an increase in the volatility index and total return index.
B
Buy
10/13/2014Downgrade
Quest Diagnostics Inc. (DGX) was downgraded to B from B+ on 10/13/2014 due to a decline in the volatility index.
Quest Diagnostics Inc. (DGX) was downgraded to B from B+ on 10/13/2014 due to a decline in the volatility index.
B
Buy
8/29/2014Upgraded
Quest Diagnostics Inc. (DGX) was upgraded to B+ from B on 8/29/2014 due to a significant increase in the growth index, volatility index and total return index. Operating cash flow increased 233.33% from $84M to $280M, earnings per share increased from $0.71 to $0.92, and EBIT increased 28.18% from $220M to $282M.
Quest Diagnostics Inc. (DGX) was upgraded to B+ from B on 8/29/2014 due to a significant increase in the growth index, volatility index and total return index. Operating cash flow increased 233.33% from $84M to $280M, earnings per share increased from $0.71 to $0.92, and EBIT increased 28.18% from $220M to $282M.
B
Buy
6/23/2014Upgraded
Quest Diagnostics Inc. (DGX) was upgraded to B from B- on 6/23/2014 due to an increase in the total return index and volatility index.
Quest Diagnostics Inc. (DGX) was upgraded to B from B- on 6/23/2014 due to an increase in the total return index and volatility index.
B
Buy
6/4/2014Upgraded
Quest Diagnostics Inc. (DGX) was upgraded to B- from C+ on 6/4/2014 due to an increase in the total return index, efficiency index and volatility index. Total capital increased 8.98% from $7.34B to $8B.
Quest Diagnostics Inc. (DGX) was upgraded to B- from C+ on 6/4/2014 due to an increase in the total return index, efficiency index and volatility index. Total capital increased 8.98% from $7.34B to $8B.
C
Hold
3/6/2014Downgrade
Quest Diagnostics Inc. (DGX) was downgraded to C+ from B- on 3/6/2014 due to a noticeable decline in the total return index and solvency index.
Quest Diagnostics Inc. (DGX) was downgraded to C+ from B- on 3/6/2014 due to a noticeable decline in the total return index and solvency index.
NYSE
03/07/2025 4:00PM Eastern
Quotes delayed
